Mycophenolic acid is an immunosuppressant medication used to treat dermatomyositis and rejection prophylaxis. Suppliers of mycophenolic acid market it in the form of 180mg and 360mg and 500mg tablets as well as powders for injectable solutions. Immunosuppressive properties of the drug were discovered in 1995. Since then, multiple manufacturers and distributors introduced mycophenolic acid formulations into the global pharmaceutical market. Among the largest mycophenolic acid medication suppliers are well-known companies Novartis, Pfizer, Roche, Teva, and Accord. Mycophenolic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified mycophenolic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Prices of mycophenolic acid medications vary depending on whether it is a generic or trade name formulation, the concentration of the active ingredient as well as manufacturer and supplier pricing. Costs per 50 (500mg) tablets of mycophenolic acid range from 30,00 EUR to 75,00 EUR.